Stockreport

Bristol-Myers Squibb down 3% premarket on diminished prospects of overtaking Merck in first-line lung cancer [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Bristol-Myers Squibb down 3% premarket on diminished prospects of overtaking Merck in first-line lung cancer [Read more]